Status:
ACTIVE_NOT_RECRUITING
Effectiveness of Group and Individual Training in EFT for Patients in Remission From Melanoma
Lead Sponsor:
Soul Medicine Institute
Collaborating Sponsors:
Tel Aviv University
Conditions:
Melanoma (Skin)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Serious medical diagnosis frequently induce fear focused on specific anticipations or generalized anxiety, along with uncertainty, insecurity, and disorientation. Other emotions such as anger, depress...
Detailed Description
Serious medical diagnosis frequently induce fear focused on specific anticipations or generalized anxiety, along with uncertainty, insecurity, and disorientation. Other emotions such as anger, depress...
Eligibility Criteria
Inclusion
- Melanoma diagnosis over six months prior to the study; confirmed by clinical, dermoscopic examination and pathology results
Exclusion
- In active treatment for melanoma
- schizophrenia
- epilepsy
- other malignant disease
Key Trial Info
Start Date :
October 20 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 20 2027
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT05421988
Start Date
October 20 2022
End Date
July 20 2027
Last Update
April 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The School Of Social Work Tel Aviv University
Tel Aviv, Israel, 69978